Education
About Us
Working with TipRanks
Follow Us
Ilika PLC (ILIKF)
OTHER OTC:ILIKF
ILIKF Stock Chart & Stats
$0.51
-$0.02(-6.96%)
At close: 4:00 PM EST
$0.51
-$0.02(-6.96%)
Day’s Range― - ―
52-Week Range$0.32 - $0.69
Previous CloseN/A
Volume9.66K
Average Volume (3M)110.77K
Market Cap
$67.70M
Enterprise Value$44.27M
Total Cash (Recent Filing)$6.92M
Total Debt (Recent Filing)$562.20K
Price to Earnings (P/E)―
Beta0.46
Next Earnings
Jul 09, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding180,832,170
10 Day Avg. Volume77,793
30 Day Avg. Volume110,768
Financial Highlights & Ratios
PEG Ratio0.29
Price to Book (P/B)2.38
Price to Sales (P/S)2413.15
P/FCF Ratio-11.75
Enterprise Value/Market Cap0.65
Enterprise Value/Revenue8.35K
Enterprise Value/Gross Profit-18.48
Enterprise Value/Ebitda-6.53
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)$37.78K
Bulls Say, Bears Say
Bulls Say
Stereax Commercialisation Via CirtecQualification of manufacturing at Cirtec plus customer deliveries and an initial cathode purchase order materially de-risks near-term manufacturing readiness. This demonstrates the company can move from lab to production, underpinning recurring cathode/electrode revenues and a clearer commercial ramp pathway over the next 2–6 months.
Goliath Prototypes And Pilot-line Scale-upValidated prototypes and an automated pilot line show technical scale-up capability, reducing engineering and deployment risk for larger-format cells. Shipping 10 Ah prototypes to OEMs supports long-term licensing prospects by converting technical validation into commercial conversations and potential future volume licensing.
Asset-light Licensing Model And IP PortfolioAn asset-light licensing strategy combined with 78 granted patents provides a durable competitive moat and scalable revenue levers. Licensing, cathode deposition and royalty streams can generate high-margin, capital-efficient income as partners adopt the tech, lowering Ilika's need for heavy capex to scale volumes itself.
Bears Say
Severe Revenue Decline And Negative MarginsA near-total revenue collapse and persistent negative margins indicate the business has yet to translate technical progress into sustainable sales or profits. This structural cash burn and lack of operating leverage mean profitability depends on converting pilots and licensing at scale, which remains uncertain over the medium term.
Negative Operating And Free Cash Flow; Reduced Cash BalanceSustained negative operating and free cash flow and a material cash decline constrain the company's ability to fund scale-up without external capital or partner financing. Reliance on grants and tax credits is helpful but increases funding risk and could delay commercialization if fresh capital or stronger cash generation isn't achieved.
Extended Timing And Validation Risk For Goliath LicensingA potential ~30-month licensing timeline and pending external validation lengthen the path to material licensing revenue. Extended conversion cycles raise execution risk, increase cumulative R&D/prototype spend, and expose Ilika to partner deprioritisation or competitive advances before large-scale revenue appears.
Ilika plc News
ILIKF FAQ
What was Ilika PLC’s price range in the past 12 months?
Ilika PLC lowest stock price was $0.32 and its highest was $0.69 in the past 12 months.
What is Ilika PLC’s market cap?
Ilika PLC’s market cap is $67.70M.
When is Ilika PLC’s upcoming earnings report date?
Ilika PLC’s upcoming earnings report date is Jul 09, 2026 which is in 125 days.
How were Ilika PLC’s earnings last quarter?
Ilika PLC released its earnings results on Jan 22, 2026. The company reported -$0.028 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.028.
Is Ilika PLC overvalued?
According to Wall Street analysts Ilika PLC’s price is currently Overvalued.
Does Ilika PLC pay dividends?
Ilika PLC does not currently pay dividends.
What is Ilika PLC’s EPS estimate?
Ilika PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ilika PLC have?
Ilika PLC has 180,832,170 shares outstanding.
What happened to Ilika PLC’s price movement after its last earnings report?
Ilika PLC reported an EPS of -$0.028 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.006%.
Which hedge fund is a major shareholder of Ilika PLC?
Currently, no hedge funds are holding shares in ILIKF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ilika plc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
89.58%
12-Months-Change
Fundamentals
Return on Equity
-31.45%
Trailing 12-Months
Asset Growth
-14.80%
Trailing 12-Months
Company Description
Ilika PLC
Ilika plc engages in the design, development, and production of solid-state batteries under the Stereax name primarily in the United Kingdom, Asia, rest of Europe, and North America. It offers batteries for a range of applications in the industrial Internet of Things, medical, transportation, electric vehicles, and cordless consumer electronics/ smart cities. The company was founded in 2004 and is headquartered in Romsey, the United Kingdom.
Technical Analysis
Ownership Overview
0.59% Insiders
<0.01% Mutual Funds
<0.01% Other Institutional Investors
99.41% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---